Inventor · disambiguated record
Antoine Decrulle
Also filed as: DECRULLE ANTOINE
24 granted patents·6 pending applications·33 citations·filing 2018–2025
94Inventor score
Files withELIGO BIOSCIENCE30
Top patents by PatentIndex Score
30 records- 0198US11633348B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Apr 25, 2023·4 cites·15 claims
- 0297US11541106B2Method for killing bacteria with an engineered postbioticELIGO BIOSCIENCE·Filed 2022·Granted Jan 3, 2023·7 cites·20 claims
- 0396US11078490B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2020·Granted Aug 3, 2021·3 cites·20 claims
- 0494US11739304B2Production of lytic phagesELIGO BIOSCIENCE·Filed 2022·Granted Aug 29, 2023·2 cites·15 claims
- 0594US11224621B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jan 18, 2022·4 cites·19 claims
- 0693US11839645B2Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·1 cites·13 claims
- 0793US11690880B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Jul 4, 2023·3 cites·19 claims
- 0892US10808254B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2019·Granted Oct 20, 2020·4 cites·19 claims
- 0991US11534467B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2022·Granted Dec 27, 2022·1 cites·23 claims
- 1089US12460216B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2024·Granted Nov 4, 2025·0 cites·17 claims
- 1188US12454696B2Cutibacterium acnes recombinant phages encoding a human proteinELIGO BIOSCIENCE·Filed 2023·Granted Oct 28, 2025·0 cites·15 claims
- 1288US11970701B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2023·Granted Apr 30, 2024·0 cites·8 claims
- 1388US11473093B2Cutibacterium acnes recombinant phages, method of production and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Oct 18, 2022·1 cites·4 claims
- 1487US11376286B2Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2021·Granted Jul 5, 2022·1 cites·18 claims
- 1587US2024218380A1Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 1686US2024182870A1Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 1786US2024247238A1Production of lytic phagesELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 1885US11952595B2Production of lytic phagesELIGO BIOSCIENCE·Filed 2023·Granted Apr 9, 2024·0 cites·19 claims
- 1985US11939598B2Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2023·Granted Mar 26, 2024·0 cites·16 claims
- 2084US11124776B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2019·Granted Sep 21, 2021·2 cites·17 claims
- 2183US11840695B2Recombinant C. acnes phages comprising transgenesELIGO BIOSCIENCE·Filed 2022·Granted Dec 12, 2023·0 cites·5 claims
- 2282US12214070B2Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2023·Granted Feb 4, 2025·0 cites·15 claims
- 2380US11697802B2Production bacterial cells and use thereof in production methodsELIGO BIOSCIENCE·Filed 2022·Granted Jul 11, 2023·0 cites·9 claims
- 2480US2023330157A1Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disordersELIGO BIOSCIENCE·Filed 2023·Application pending·0 cites
- 2580US2024209326A1Bacterial delivery vehicle, process of production and uses thereofELIGO BIOSCIENCE·Filed 2024·Application pending·0 cites
- 2679US11820989B2Phage-derived particles for in situ delivery of DNA payload into C. acnes populationELIGO BIOSCIENCE·Filed 2021·Granted Nov 21, 2023·0 cites·18 claims
- 2778US11946056B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2021·Granted Apr 2, 2024·0 cites·15 claims
- 2873US11952594B2Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereofELIGO BIOSCIENCE·Filed 2021·Granted Apr 9, 2024·0 cites·15 claims
- 2969US11905516B2Optimized vector for delivery in microbial populationsELIGO BIOSCIENCE·Filed 2018·Granted Feb 20, 2024·0 cites·20 claims
- 3066US2025144006A1Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysinsELIGO BIOSCIENCE·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antoine Decrulle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →